Skip to Main

News

UTSW researchers boost the power of CAR T cells to fight cancer

 

UT Southwestern Medical Center researchers have discovered that increasing the levels of a protein called BACH2 makes engineered cancer-fighting immune cells behave more like stem cells, improving their therapeutic effectiveness.

UT Southwestern biochemist Zhijian ‘James’ Chen to receive 2026 Japan Prize

 

Zhijian “James” Chen, Ph.D., Professor of Molecular Biology at UT Southwestern Medical Center and one of the world’s top researchers on how the body’s immune system protects us against threats such as bacteria and viruses, has been awarded the 2026 Japan Prize in Life Sciences – one of the highest international honors for science and technology.

Most patients support AI to help read mammograms with doctor oversight

 

Artificial intelligence (AI) has become a go-to tool in health care, helping clinicians such as radiologists make diagnoses and personalize care. But what do patients think about this?

UTSW first in Texas to offer novel treatment for rare eye cancer that spreads to the liver

 

A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic uveal melanoma, a rare and deadly eye cancer.

Study reveals molecular ‘switch’ that turns on inflammation in obesity

 

A team led by UT Southwestern Medical Center researchers has uncovered a molecular pathway that links obesity to widespread inflammation, providing long-sought insight into why obesity increases the risk of Type 2 diabetes, cardiovascular disease, fatty liver disease, and certain cancers.